Analyst Ratings for Jasper Therapeutics (JSPR)
JSPR Rating Summary
JSPR Price Target Summary
- Highest: $29.00 (UBS)
- Lowest: $4.00 (BMO Capital)
- Average: $13.38
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$13.38 (+869.2%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
Avg. $ Target:
$13.38 (+869.2%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/13/2026 | Rodman & Renshaw | Michael King Jr. | New Coverage | Buy (N/A) |
17.00 (N/A) |
1.48 (1.38) |
-6.76% | Details |
| 7/8/2025 | RBC Capital » Updated 11/11/2025 |
Leonid Timashev | Downgrade | Sector Perform (Outperform) |
4.00 (5.00) |
3.04 (1.38) |
-54.61% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
